Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
about
Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaProtein-driven inference of miRNA-disease associationsPROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data.MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.Identification of microRNA-615-3p as a novel tumor suppressor in non-small cell lung cancerNon-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancerUnique microRNA-profiles in EGFR-mutated lung adenocarcinomas.A mathematical model for microRNA in lung cancerIntegrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.Large-scale screens of miRNA-mRNA interactions unveiled that the 3'UTR of a gene is targeted by multiple miRNAsProtein expression profile of rat type two alveolar epithelial cells during hyperoxic stress and recovery.Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.Allelic imbalance in the miR-31 host gene locus in lung cancer--its potential role in carcinogenesis.Applications of MicroRNAs in the Diagnosis and Prognosis of Lung CancerDNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues.MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.Smoking and microRNA dysregulation: a cancerous combination.microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathwayMicroRNAs and lung cancers: from pathogenesis to clinical implicationsOncogenes associated with drug resistance in ovarian cancer.Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.Long-Term Cigarette Smoke Exposure and Changes in MiRNA Expression and Proteome in Non-Small-Cell Lung Cancer.miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin.MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2.MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer.Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.DNA strand-displacement-induced fluorescence enhancement for highly sensitive and selective assay of multiple microRNA in cancer cells.Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells.Serum microRNA-150 predicts prognosis for early-stage non-small cell lung cancer and promotes tumor cell proliferation by targeting tumor suppressor gene SRCIN1.MicroRNAs - Important Molecules in Lung Cancer Research.MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression.MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1.Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer
P2860
Q26743361-9EE10B93-5279-475B-AE47-252CE1CF45C7Q30002355-5ED5BDE3-9457-4888-A191-48136B723514Q30583504-C9AF13A5-2387-4638-93C4-F5B682532C1BQ33568404-B4CF40D6-01A6-41CC-9367-8148D288CEDDQ33598046-95961B23-C5EA-465F-96DC-02A9FF439702Q33648562-788E3E31-A471-4CB1-89C4-E89154C01CC8Q33720291-AA2136A0-B132-4A3F-9B0D-1E4EB5C6D0BEQ34531091-8637D7E7-50F1-48D8-B3B3-DEC688FFF722Q34568201-62FBB1B5-5AB0-4546-B347-BCD48B459D48Q34584599-33319BA7-8429-41F1-9CAE-B4FAFD0A37B5Q34847325-6626CCC0-6D11-45C1-AD80-AE0FB4B8B24BQ34981165-F5EAE276-AF35-43B8-9E36-A9DC4928CA9BQ35113376-52005D2F-A97A-4007-8B42-D3CBEC402279Q35198062-3B3764E1-AEA7-4948-96AD-317D98B0CC95Q35970795-A768B314-754D-46D6-A81B-8BD71AFEEC0FQ36298188-6AAE0399-EF15-4C55-AB7A-E568D47E2974Q36411401-77D3FF08-2EE5-449D-98AD-4FE47152A991Q36464350-D4DB26F3-5BCB-4035-935F-54F89D328723Q36927000-5E0A3718-EF3E-44D4-A2D0-CB19B3707D86Q37432727-A6CD2539-D2C4-417D-97D3-45E42B837090Q37520214-4C6AA288-EBBC-4938-AD50-5CB722AA5940Q38005062-9856D449-30D0-45A6-8795-80DBF7A2C95EQ38226577-B288EFC0-DEAE-44E5-B56B-741446100B80Q38373911-C36F6492-E185-4541-850C-07578CA5CB4EQ38430180-E462EC9A-7CCD-4A15-862D-62D8DBD785EAQ38431483-39882930-FFF6-4FC2-838F-3BD1C73D1324Q38766169-795F7F87-5BD8-4F05-8822-1FC8C787FF74Q38815853-BF21B8CB-3651-4FB7-8B6D-A96C2A1082E8Q38840848-CB83FCC7-6CFC-4DB8-B067-1652FC3FAD09Q38887635-90F96815-D88E-42AD-86BE-49D2B73D7B5EQ39032730-9C58CC56-B404-4DEA-A62C-558AD2B12826Q39048063-DE3B38D1-F6E7-4DD2-B9B2-EAE70A0A491EQ39070080-A46D3713-B90B-4C9F-B73C-8D628EE7B5D3Q39375782-3210067A-9363-4ED7-89EC-9AF68F5AE5D3Q40048290-1721686B-490D-4E17-BD5F-750C7A0656F6Q40575902-15947446-ACAD-42BF-BC2D-52A913277296Q40846602-C9A762F3-20E9-43C8-9B71-AF5D90D901ADQ40996231-D7469197-E022-4925-9978-6FCE34E68F1BQ41024459-2BA27139-9007-4744-AD19-6B269BBD559FQ41552614-F48591D8-84E9-489E-9FB2-B981F29D6812
P2860
Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@ast
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@en
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@nl
type
label
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@ast
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@en
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@nl
prefLabel
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@ast
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@en
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@nl
P2093
P2860
P50
P356
P1476
Identification of miR-374a as ...... age nonsmall cell lung cancer.
@en
P2093
Kristjan Välk
Neeme Tõnisson
Retlav Roosipuu
Tõnu Vooder
P2860
P304
P356
10.1002/GCC.20902
P577
2011-07-11T00:00:00Z